Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance

被引：0
|
作者：
Lucien Torlot
Anna Jarzab
Johanna Albert
Ágnes Pók-Udvari
Arndt Stahler
Julian Walter Holch
Marco Gerlinger
Volker Heinemann
Frederick Klauschen
Thomas Kirchner
Jörg Kumbrink
Bernhard Küster
Andreas Jung
机构：
[1] Ludwig-Maximilians-University (LMU),Institute of Pathology
[2] German Cancer Consortium (DKTK),Chair or Proteomics and Bioanalytics
[3] Technical University of Munich,Department of Hematology, Oncology, and Cancer Immunology
[4] Charité - Universitätsmedizin Berlin,Department of Medicine III
[5] Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin,Comprehensive Cancer Center Munich (CCCM)
[6] German Cancer Consortium (DKTK),Translational Oncogenomics Lab
[7] LMU Hospital,Barts Cancer Institute
[8] LMU Hospital,Gastrointestinal Cancer Unit
[9] The Institute of Cancer Research,undefined
[10] Queen Mary University of London,undefined
[11] St Bartholomew’s Hospital,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Colorectal cancer; EPHA2; Cetuximab resistance; Molecular oncology; Proteomics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：669 / 682
页数：13
相关论文
共 50 条
  • [31] EphA2 as a phase separation protein associated with ferroptosis and immune cell infiltration in colorectal cancer
    Li, Yanling
    Peng, Qiu
    Wang, Lujuan
    AGING-US, 2023, 15 (22): : 12952 - 12965
  • [32] Overcoming intrinsic and acquired cetuximab resistance: an in vitro study on the potential of afatinib in HNSCC cell lines
    De Pauw, Ines
    Wouters, An
    Van den Bossche, Jolien
    Deschoolmeester, Vanessa
    Pauwels, Patrick
    Vermorken, Jan B.
    Peeters, Marc
    Lardon, Filip
    CANCER RESEARCH, 2017, 77
  • [33] Quantitative Proteomics of Urinary Bladder Cancer Cell Lines Identify UAP1 as a Potential Therapeutic Target
    Puttamallesh, Vinuth N.
    Deb, Barnali
    Gondkar, Kirti
    Jain, Ankit
    Nair, Bipin
    Pandey, Akhilesh
    Chatterjee, Aditi
    Gowda, Harsha
    Kumar, Prashant
    GENES, 2020, 11 (07) : 1 - 17
  • [34] Correction: Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma
    Hailong Ruan
    Sen Li
    Lin Bao
    Xiaoping Zhang
    Oncogene, 2023, 42 : 165 - 167
  • [35] CetuximabDevelopment of acquired cetuximab-resistance in colorectal-cancer: 2 case reports
    Reactions Weekly, 2017, 1644 (1) : 78 - 78
  • [36] EPHA2 blockade overcomes primary and acquired resistance to anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer (mCRC)
    Martini, G.
    Belli, V.
    Vitiello, P. P.
    Troiani, T.
    Cardone, C.
    Napolitano, S.
    Desiderio, V.
    Sforza, V.
    Ferrara, M. L.
    Papaccio, G.
    Mele, L.
    Liguori, G.
    Botti, G.
    Franco, R.
    Morgillo, F.
    Ciardiello, F.
    Martinelli, E.
    ANNALS OF ONCOLOGY, 2016, 27
  • [37] EPHA2 receptor is involved in in vivo acquired resistance to anti-Epidermal Growth Factor Receptor (EGFR) treatment in metastatic colorectal cancer (mCRC)
    Martini, G.
    Belli, V.
    Vitiello, P. P.
    Troiani, T.
    Cardone, C.
    Napolitano, S.
    Matrone, N.
    Sforza, V.
    Franco, R.
    Morgillo, F.
    Ciardiello, D.
    Giunta, E.
    De Falco, V.
    Zanaletti, N.
    Vitale, P.
    Martinelli, E.
    Ciardiello, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [38] Dysregulation of EGFR Pathway in EphA2 Cell Subpopulation Significantly Associates with Poor Prognosis in Colorectal Cancer
    De Robertis, Mariangela
    Loiacono, Luisa
    Fusilli, Caterina
    Poeta, Maria Luana
    Mazza, Tommaso
    Sanchez, Massimo
    Marchionni, Luigi
    Signori, Emanuela
    Lamorte, Giuseppe
    Vescovi, Angelo Luigi
    Garcia-Foncillas, Jesus
    Fazio, Vito Michele
    CLINICAL CANCER RESEARCH, 2017, 23 (01) : 159 - 170
  • [39] EphA2 receptor activation with ephrin-A1 ligand restores cetuximab efficacy in NRAS-mutant colorectal cancer cells
    Cuyas, Elisabet
    Queralt, Bernardo
    Martin-Castillo, Begona
    Bosch-Barrera, Joaquim
    Menendez, Javier A.
    ONCOLOGY REPORTS, 2017, 38 (01) : 263 - 270
  • [40] Systems analysis identifies potential target genes to overcome cetuximab resistance in colorectal cancer cells
    Park, Sang-Min
    Hwang, Chae Young
    Cho, Sung-Hwan
    Lee, Daewon
    Gong, Jeong-Ryeol
    Lee, Soobeom
    Nam, Sohee
    Cho, Kwang-Hyun
    FEBS JOURNAL, 2019, 286 (07) : 1305 - 1318
12345